Persistent auditory hallucinations

Psychopathology
J C GonzálezJ Sanjuan

Abstract

There is still a significant proportion of psychotic patients who suffer from persistent auditory hallucinations (PAH) in spite of treatment. The objective of our study was to analyze those clinical dimensions that characterize persistent hallucinators in comparison with episodic hallucinators. Ninety-one outpatients with AH were assessed through semistructured interviews. The interviews included the Psychotic Symptom Rating Scales for AH and the Krawiecka scale. They elicited descriptions about the persistence of AH, existence of pleasurable hallucinations and other types of hallucinations. Forty-five patients fulfilled criteria for reported PAH. Persistent hallucinators showed greater scores in frequency and duration of hallucinations, Krawiecka total score and incoherence of speech. Moreover, pleasurable experiences were more frequent in this group of patients. Logistic regression analysis rendered a model with the following variables: duration of voices, degree of control and pleasurable hallucinations. Specific dimensions of AH can predict the possibility of treatment resistance.

References

Apr 1, 1990·The Journal of Nervous and Mental Disease·H H Hustig, R J Hafner
Jan 1, 1989·Schizophrenia Bulletin·M A Romme, A D Escher
Aug 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·P F Liddle
Mar 1, 1985·The Journal of Nervous and Mental Disease·J Junginger, C L Frame
Jun 1, 1967·Journal of Psychiatric Research·S G KellamJ L Shmelzer
May 1, 1981·Psychological Medicine·I R Falloon, R E Talbot
Sep 1, 1981·The British Journal of Medical Psychology·M Judkins, P Slade
Jul 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·R Persaud, I Marks
Aug 1, 1995·Acta Psychiatrica Scandinavica·P G OulisC N Stefanis
Feb 1, 1996·The American Journal of Psychiatry·L J Miller
Mar 1, 1996·The Journal of Nervous and Mental Disease·D M CarterD L Copolov
Jan 1, 1996·Psychological Medicine·T H Nayani, A S David
Apr 1, 1996·Behaviour Research and Therapy·P Chadwick, P Trower
Aug 29, 1997·Schizophrenia Research·P CheungV Tuckwell
Jan 1, 1997·Schizophrenia Bulletin·R R Conley, R W Buchanan
Aug 14, 1998·Molecular Psychiatry·K P Lesch
Aug 28, 1998·Schizophrenia Research·S S ShergillP K McGuire
May 4, 1999·Acta Psychiatrica Scandinavica. Supplementum·A S David
Sep 9, 1999·Schizophrenia Bulletin·W E BunneyC A Sandman
Feb 7, 2001·Schizophrenia Bulletin·P A GaretyE Kuipers
Feb 24, 2001·The Journal of Clinical Psychiatry·D L GarverJ D Christensen
Mar 10, 2001·Psychological Medicine·P A GaretyP E Bebbington
Jul 8, 2003·Psychopathology·Giovanni Stanghellini, John Cutting
Jun 1, 1965·Archives of General Psychiatry·R H MOTTJ M ANDERSON
Sep 9, 2004·Acta Psychiatrica Scandinavica·J SanjuanJ van Os
Sep 15, 2004·European Psychiatry : the Journal of the Association of European Psychiatrists·J SanjuanR De Frutos
Mar 31, 2006·Cognitive Neuropsychiatry·P W R Woodruff

❮ Previous
Next ❯

Citations

Aug 22, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·F-W LungP-F Chen
Nov 27, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Massimo C MauriGiorgio Marotta
Mar 31, 2011·Journal of Clinical Psychology·Guillem LeraCarmen Leal
Dec 11, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Katharina M KuberaR Christian Wolf
Apr 15, 2014·British Journal of Hospital Medicine·James P Pandarakalam
Jan 29, 2021·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·In Won ChungYong Sik Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
R Persaud, I Marks
Archives of Psychiatric Nursing
J A Frederick, M R Killeen
The American Journal of Psychiatry
Stephen E NicolsonCharles B Nemeroff
Progress in Neuro-psychopharmacology & Biological Psychiatry
Gracián García-MartíJ Sanjuan
© 2021 Meta ULC. All rights reserved